טוען...
Have we pushed the needle for treatment of Type 1 diabetes?
Studies with immunologics have shown that the natural history of Type 1 diabetes can be modified. These studies have targeted key mediators of the disease and recent analyses, together with studies in preclinical models have identified mechanisms that may be involved in the clinical effects. Several...
שמור ב:
| הוצא לאור ב: | Curr Opin Immunol |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5937133/ https://ncbi.nlm.nih.gov/pubmed/28992525 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coi.2017.09.004 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|